• News
  • Publications
  • Videos
  • Events
  • About
  • Contact

Drug development

Xenograft and organoid model systems...

July 18, 2019

Xenograft and organoid model systems in cancer research

Introduction Cancers consist of a continuously evolving heterogeneous cell mass (McGranahan &...

publicationsLearn More>

Morphophenotypic classification of tumor organoids...

July 18, 2019

Morphophenotypic classification of tumor organoids as an indicator of drug exposure and penetration potential

AbstractThe dynamics of tumor progression is driven by multiple factors, which can...

publicationsLearn More>

Organoids: A new window into...

July 16, 2019

Organoids: A new window into disease, development and discovery

Scientists have found ways of culturing organ-specific tissue from stem cells that...

newsLearn More>

Posts navigation

Newer posts

Weekly Digest

Sign up to receive
weekly updates!

    No Spum Guarantee

    Cancer Types

    • Bladder Cancer Research (2)
    • Bowel Cancer Research (3)
    • Brain Cancer Research (7)
    • Breast cancer (6)
    • cervical cancer (1)
    • colon (1)
    • Colon cancer (14)
    • colorectal cancer (6)
    • Drug development (12)
    • Endometrial cancer (2)
    • Esophageal cancer (3)
    • Gastric cancer (5)
    • Hans Clevers (1)
    • Head and neck cancer (4)
    • Immunotherapy (0)
    • Intestinal cancer (8)
    • intestinal organoids (1)
    • Kidney cancer (3)
    • Leukemia (1)
    • Liver cancer (11)
    • Lung cancer (4)
    • melanoma (1)
    • metastatic cancer (1)
    • Organoid (143)
    • Ovarian cancer (8)
    • Pancreatic cancer (19)
    • Peritoneal cancer (1)
    • Personalized medicine (5)
    • Prostate cancer (7)
    • Rectal cancer (1)
    • solid tumor (1)
    • stem cells (1)

    ORG
    1-617-547-9443

    Monday-Friday: 8 am - 8 pm
    Saturday: 8 am - 4:30 pm

    • News
    • Publications
    • Videos
    • Events
    • About Us
    • Contact Us
    • Privacy
    • Terms of Use

    © COPYRIGHT 2023 Organoid Research Group. ALL RIGHTS RESERVED.